Mindfulness-Based Therapy for Opioid Misuse Offers High Return on Investment

A groundbreaking economic evaluation conducted by the University of California San Diego School of Medicine has shed light on the remarkable cost-effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE), a pioneering therapy designed to combat opioid misuse and chronic pain. According to the study, for every dollar invested in MORE, patients reap $12 in cost savings, making it significantly more cost-effective than traditional treatments such as residential or intensive outpatient therapy.

The analysis, which took into account the long-term benefits of MORE, revealed that the cumulative savings per patient over the course of their lifetime can exceed $324,000. This staggering figure underscores the potential of MORE to not only improve patient outcomes but also alleviate the economic burden on the healthcare system. By providing a more sustainable and effective approach to treating addiction and chronic pain, MORE has the potential to revolutionize the way we address these complex health issues.

The findings of this study have far-reaching implications for policymakers, healthcare providers, and patients alike. As the nation grapples with the opioid epidemic and the rising costs of healthcare, the cost-effectiveness of MORE offers a beacon of hope for a more efficient and effective approach to treating addiction and chronic pain. Further research and implementation of this innovative therapy could lead to significant reductions in healthcare costs and improved patient outcomes, making it an essential tool in the fight against addiction and chronic pain.